Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.
Also called NCT01158846
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT01158846
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01158846. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
- Condition
- ST-Elevation Myocardial Infarction
- Condition
- Primary Percutaneous Coronary Intervention
- Intervention (Drug)
- prasugrel/bivalirudin
- Intervention (Drug)
- clopidogrel/abciximab
- Lead sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- Collaborator
- Centro Cardiologico Monzino
- Collaborator
- Azienda Ospedaliera Niguarda Cà Granda
- Collaborator
- Istituto Clinico Humanitas
Record details
- Record id
cardio:ct-nct01158846- Content hash
41a5d53f40c4b5757ef78a8dfe80162e639fdf3e117e61567436f5a150d6550a